Psychiatric pharmacists need to understand where novel treatments like inhaled loxapine, dexmedetomidine sublingual film, or intranasal olanzapine fit into the treatement of agitation in high-risk patients. This topic will be presented during the 2025 AAPP Summit. Join us! #psychpharm #bcpp #aapp